Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
Mary E.W. Collier, Shaowei Zhang, Nigel S. Scrutton, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 6, pp. 1473-1481
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The kynurenine pathway relates to post‐acuteCOVID‐19 objective cognitive impairment andPASC
Lucette A. Cysique, David Jakabek, Sophia G. Bracken, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 8, pp. 1338-1352
Open Access | Times Cited: 28
An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway
Laiba Jamshed, Amrita Debnath, Shanza Jamshed, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6300-6300
Open Access | Times Cited: 34
Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress
Melike Küçükkarapınar, Ayşegul Yay, Yeşim Yıldız, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 8, pp. 1077-1089
Open Access | Times Cited: 30
Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity
Ali Rahnavard, Brendan T. Mann, Abhigya Giri, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Neurobiological mechanisms in the kynurenine pathway and major depressive disorder
Amanda Gollo Bertollo, Maiqueli Eduarda Dama Mingoti, Zuleide Maria Ignácio
Reviews in the Neurosciences (2024)
Closed Access | Times Cited: 6
Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation
Francisco C. Ceballos, Ana Virseda‐Berdices, Salvador Resino, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study
Lucette A. Cysique, David Jakabek, Sophia G. Bracken, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 23
Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction
Samantha Lodge, Nathan G. Lawler, Nicola Gray, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11614-11614
Open Access | Times Cited: 11
Sensitive Detection of Kynurenic Acid from Biological Fluids Using a Flexible Electrochemical Platform Based on Gold Nanoparticles and Reduced Graphene Oxide
Diana-Gabriela Macovei, Mihaela Tertiş, Diana Bogdan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 913-913
Open Access
Involvement of virus infections and antiviral agents in schizophrenia
Alejandro Borrego-Ruiz, Juan J. Borrego
Psychological Medicine (2025) Vol. 55
Closed Access
Cognitive Sequelae of COVID‐19: Mechanistic Insights and Therapeutic Approaches
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia
Marco Chilosi, Claudio Doglioni, Claudia Ravaglia, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1332-1332
Open Access | Times Cited: 17
Altered Tryptophan-Kynurenine Pathway in Delirium: A Review of the Current Literature
Hui Phing Ang, Suzana Makpol, Muhammad Luqman Nasaruddin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5580-5580
Open Access | Times Cited: 9
Metabolic predictors of COVID-19 mortality and severity: a survival analysis
Abdallah Abdallah, Asmma Doudin, Theeb Osama Sulaiman, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Customized flexible platform - starting point for the development of wearable sensor for the direct electrochemical detection of kynurenic acid in biological samples
Maria‐Bianca Irimeș, Mihaela Tertiş, Diana Bogdan, et al.
Talanta (2024) Vol. 280, pp. 126684-126684
Open Access | Times Cited: 3
Altered kynurenine pathway metabolism in patients with ankylosing spondylitis
Duygu Eryavuz Onmaz, Abdullah Sivrikaya, Kevser Işık, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108018-108018
Closed Access | Times Cited: 21
An integrative analysis of Qingfei Paidu Decoction for its anti-HCoV-229E mechanism in cold and damp environment based on the pharmacokinetics, metabolomics and molecular docking technology
Yan Zhang, Xinru Gu, Yanyan Zhou, et al.
Phytomedicine (2022) Vol. 108, pp. 154527-154527
Open Access | Times Cited: 12
Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
Francisco Irochima Pinheiro, Irami Araújo-Filho, Amália Cinhtia Meneses Rêgo, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102250-102250
Closed Access | Times Cited: 2
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin
Ezio Bettini, Sara De Martin, Andrea Mattarei, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 882-882
Open Access | Times Cited: 10
Quantitative LC–MS study of compounds found predictive of COVID-19 severity and outcome
Ivayla Roberts, Marina Wright Muelas, Joseph M. Taylor, et al.
Metabolomics (2023) Vol. 19, Iss. 11
Open Access | Times Cited: 6
Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19
Abigail García‐Castro, Alma Delia Román‐Gutiérrez, Araceli Castañeda‐Ovando, et al.
Foods (2022) Vol. 11, Iss. 20, pp. 3231-3231
Open Access | Times Cited: 9
Schizophrenia and the COVID-19 pandemic: A narrative review from the biomedical perspective
Krzysztof Kowalski, Błażej Misiak
Revista de Psiquiatría y Salud Mental (2023)
Closed Access | Times Cited: 5
Post-Covid Syndrome: from Biology to Neuropsychology
Anna Е. Karchevskaya, Y. O. Vologdina, О. С. Зайцев, et al.
Moscow University Psychology Bulletin (2024) Vol. 47, Iss. 1, pp. 31-55
Open Access | Times Cited: 1
Integrated RNA-seq and RNAi Analysis of the Roles of the Hsp70 and SP Genes in Red-Shell Meretrix meretrix Tolerance to the Pathogen Vibrio parahaemolyticus
Yun Zheng, Shanjie Zha, Weifeng Zhang, et al.
Marine Biotechnology (2022) Vol. 24, Iss. 5, pp. 942-955
Open Access | Times Cited: 7
Changes in glomerular filtration rate and metabolomic differences in severely ill coronavirus disease survivors 3 months after discharge
Mei Zhou, Xueyun Tan, Ping Luo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 1, pp. 166289-166289
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top